SAN DIEGO, Aug. 5, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will provide a corporate presentation on Tuesday, August 9 at 5:00 p.m. at the 2011 Canaccord Genuity Growth Conference. The presentation will take place in Boston, Massachusetts at the Intercontinental Hotel.
